- Home
- ACLS vs CRNX Comparison
ACLS vs CRNX Comparison
Compare ACLS & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACLS
- CRNX
- Stock Information
- Founded
- ACLS 1995
- CRNX 2008
- Country
- ACLS United States
- CRNX United States
- Employees
- ACLS N/A
- CRNX N/A
- Industry
- ACLS Industrial Machinery/Components
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- ACLS Technology
- CRNX Health Care
- Exchange
- ACLS Nasdaq
- CRNX Nasdaq
- Market Cap
- ACLS 3.6B
- CRNX 4.2B
- IPO Year
- ACLS 2000
- CRNX 2018
- Fundamental
- Price
- ACLS $96.98
- CRNX $50.39
- Analyst Decision
- ACLS Strong Buy
- CRNX Strong Buy
- Analyst Count
- ACLS 6
- CRNX 12
- Target Price
- ACLS $169.80
- CRNX $66.00
- AVG Volume (30 Days)
- ACLS 498.3K
- CRNX 491.4K
- Earning Date
- ACLS 10-30-2024
- CRNX 08-08-2024
- Dividend Yield
- ACLS N/A
- CRNX N/A
- EPS Growth
- ACLS 16.96
- CRNX N/A
- EPS
- ACLS 7.27
- CRNX N/A
- Revenue
- ACLS $1,111,497,000.00
- CRNX $1,385,000.00
- Revenue This Year
- ACLS N/A
- CRNX N/A
- Revenue Next Year
- ACLS $13.09
- CRNX $505.26
- P/E Ratio
- ACLS $13.35
- CRNX N/A
- Revenue Growth
- ACLS 8.63
- CRNX N/A
- 52 Week Low
- ACLS $93.77
- CRNX $15.76
- 52 Week High
- ACLS $183.13
- CRNX $55.78
- Technical
- Relative Strength Index (RSI)
- ACLS 33.40
- CRNX 43.81
- Support Level
- ACLS $97.77
- CRNX $52.70
- Resistance Level
- ACLS $102.05
- CRNX $53.42
- Average True Range (ATR)
- ACLS 4.44
- CRNX 1.82
- MACD
- ACLS -0.83
- CRNX -0.35
- Stochastic Oscillator
- ACLS 5.05
- CRNX 11.94
About ACLS Axcelis Technologies Inc.
Axcelis Technologies Inc designs, manufactures and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provide aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services and customer training. Geographically, the group has a business presence in North America, Asia Pacific and Europe, of which key revenue is derived from the Asia Pacific.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.